23rd week of 2022 patent applcation highlights part 9 |
Patent application number | Title | Published |
20220175659 | FERMENT FROM STRUCTURED WATER MEDIUM AND COSMETIC COMPOSITION COMPRISING THE SAME | 2022-06-09 |
20220175660 | COMPOSITIONS FOR THE TREATMENT OF SKIN CONDITIONS | 2022-06-09 |
20220175661 | SYNERGIST THERAPY FOR ENHANCED DRUG DELIVERY: MAGNETIC FIELD FACILITATED NANOPARTICLE MICROPORATION | 2022-06-09 |
20220175662 | SUSTAINED RELEASE DEVICE FOR TREATMENT OF PARKINSON'S DISEASE AND OTHER DISORDERS | 2022-06-09 |
20220175663 | STABLE LIQUID ANTIBODY FORMULATION | 2022-06-09 |
20220175664 | TUMESCENT INFILTRATION DRUG DELIVERY OF HIGH SUBCUTANEOUS DRUG CONCENTRATIONS WITH PROLONGED LOCAL AND SYSTEMIC EFFECTS AND MINIMAL LOCAL OR SYSTEMIC TOXICITY | 2022-06-09 |
20220175665 | TUMESCENT INFILTRATION DRUG DELIVERY OF HIGH SUBCUTANEOUS DRUG CONCENTRATIONS WITH PROLONGED LOCAL AND SYSTEMIC EFFECTS AND MINIMAL LOCAL OR SYSTEMIC TOXICITY | 2022-06-09 |
20220175666 | INJECTION FORMULATION COMPOSITION CONTAINING MESENCHYMAL STEM CELL-HYDROGEL AND METHOD FOR PREPARING, FREEZING AND DEFROSTING SAME | 2022-06-09 |
20220175667 | Extracellular Matrices, Uses Thereof, and Methods of Making Extracellular Matrices | 2022-06-09 |
20220175668 | AQUEOUS OPHTHALMIC SOLUTIONS OF PHENTOLAMINE AND MEDICAL USES THEREOF | 2022-06-09 |
20220175669 | CHEWABLE PHARMACEUTICAL PRODUCT FOR DELIVERY OF COLESEVELAM HYDROCHLORIDE | 2022-06-09 |
20220175670 | DEVICES AND METHODS FOR DELIVERY OF SUBSTANCES TO ANIMALS | 2022-06-09 |
20220175671 | ROCKET-SHAPED RECTAL SUPPOSITORY | 2022-06-09 |
20220175672 | COMPOSITIONS AND METHODS FOR SUSTAINED DRUG RELEASE FROM AN INJECTABLE HYDROGEL | 2022-06-09 |
20220175673 | SURGICAL DEVICE | 2022-06-09 |
20220175674 | HIGH CONCENTRATION CELL PACKAGING AND SHIPPING | 2022-06-09 |
20220175675 | ENCAPSULATING MOLECULES IN FAT GLOBULES | 2022-06-09 |
20220175676 | MULTIFUNCTIONAL POLYMER-NANOPARTICLE COMPOSITE FOR FIRST AID AND WOUND CARE APPLICATIONS | 2022-06-09 |
20220175677 | METHODS OF IMPROVING PHARMACEUTICAL SUBSTANCE SOLUBILIZATION AND PRODUCTS THEREOF | 2022-06-09 |
20220175678 | FORMULATIONS FOR ENCAPSULATION AND BIOAVAILABILITY IMPROVEMENT OF BIOACTIVE COMPOUNDS BASED ON NATURAL PLANT BASED MATERIALS | 2022-06-09 |
20220175679 | COMPOSITIONS OF MIDODRINE AND METHODS OF USING THE SAME | 2022-06-09 |
20220175680 | PHARMACEUTICAL COMPOSTION CONTAINING ACETOMINOPHEN AND IBUPROFEN | 2022-06-09 |
20220175681 | SELF-RIGHTING ARTICLES | 2022-06-09 |
20220175682 | Siremadlin Succinate | 2022-06-09 |
20220175683 | IMPROVED API STABILITY IN SOFTGELS | 2022-06-09 |
20220175684 | COMPOSITION FOR CONTROLLED RELEASE OF PHYSIOLOGICALLY ACTIVE SUBSTANCES AND PROCESS FOR ITS PREPARATION | 2022-06-09 |
20220175685 | STABLE DISPERSIONS OF SILVER NANOPARTICLES AND METHODS OF PREPARATION THEREOF | 2022-06-09 |
20220175686 | NANOPARTICLE, METHOD FOR PRODUCING NANOPARTICLE, AND PHARMACEUTICAL COMPOSITION | 2022-06-09 |
20220175687 | NANOPARTICLES FOR DRUG DELIVERY TO BRAIN | 2022-06-09 |
20220175688 | POLYMERIC NANOPARTICLES | 2022-06-09 |
20220175689 | NOVEL DRUG DELIVERY COMPOSITION AND PROCESS FOR BLOOD-BRAIN BARRIER CROSSING | 2022-06-09 |
20220175690 | NOVEL DRUG DELIVERY COMPOSITION AND PROCESS FOR BLOOD-BRAIN BARRIER CROSSING | 2022-06-09 |
20220175691 | DELIVERY SYSTEMS FOR RELEASE OF ACTIVE COMPOUNDS | 2022-06-09 |
20220175692 | PRESYNAPTIC GLUTAMATE RELEASE INHIBITORS FOR DECREASING NMDA ANTAGONIST SIDE EFFECTS IN ANESTHESIA | 2022-06-09 |
20220175693 | DIETARY SUPPLEMENT COMPRISING LUTEIN FOR TELOMERE PROTECTION, AND METHOD FOR PRODUCTION THEREOF | 2022-06-09 |
20220175694 | Anti-Aging Therapy for Canines and Other Domesticated Animals | 2022-06-09 |
20220175695 | FORTIFICANT COMPOSITION | 2022-06-09 |
20220175696 | PROMOTION OF LYMPHATIC FUNCTION | 2022-06-09 |
20220175697 | COMPOSITIONS AND METHODS OF TREATING AGE-RELATED MACULAR DEGENERATION | 2022-06-09 |
20220175698 | COMBINATIONS OF IADADEMSTAT FOR CANCER THERAPY | 2022-06-09 |
20220175700 | VISUAL CYCLE MODULATORS | 2022-06-09 |
20220175701 | TREATMENT OF MAJOR DEPRESSIVE DISORDER AND SUICIDAL IDEATIONS THROUGH STIMULATION OF HIPPOCAMPAL NEUROGENESIS UTILIZING PLANT-BASED APPROACHES | 2022-06-09 |
20220175702 | SUSTAINED RELEASE COMPOSITIONS OF ENDOXIFEN | 2022-06-09 |
20220175703 | Compositions and Methods of Achieving Pain Relief | 2022-06-09 |
20220175704 | SENSITIZATION OF CANCER CELLS TO DIFFERENTIATION THERAPY WITH MITOCHONDRIAL UNCOUPLER NICLOSAMIDE ETHANOLAMINE | 2022-06-09 |
20220175705 | DISULFIDE-MASKED PRO-CHELATOR COMPOSITIONS AND METHODS OF USE | 2022-06-09 |
20220175706 | CALCIUM LACTATE COMPOSITIONS AND METHODS OF USE | 2022-06-09 |
20220175707 | PREGABALIN FORMULATIONS AND USE THEREOF | 2022-06-09 |
20220175708 | COMPOSITIONS AND METHODS FOR INCREASING MUSCLE MASS AND STRENGTH, TREATING SKIN, REDUCING WEAR AND DEGRADATION FROM AGING AND EXPOSURE AND IMPROVING RECOVERY FROM STRESS SUCH AS EXERCISE AND TRAUMA | 2022-06-09 |
20220175709 | PHARMACEUTICAL COMPOSITION COMPRISING EICOSAPENTAENOIC ACID AND NICOTINIC ACID AND METHODS OF USING SAME | 2022-06-09 |
20220175710 | COMBINATION THERAPY | 2022-06-09 |
20220175711 | OILS WITH ANTI-INFLAMMATORY ACTIVITY CONTAINING NATURAL SPECIALIZED PRORESOLVING MEDIATORS AND THEIR PRECURSORS | 2022-06-09 |
20220175712 | USE OF CAPRYLIC AND CAPRIC TRIGLYCERIDES FOR THE TREATMENT OF A DISEASE OR CONDITION MEDIATED BY FILAGGRIN OR COLLAGEN DEFICIENCY | 2022-06-09 |
20220175713 | DEPSIDE TRIMERIC COMPOUNDS FOR SKELETAL MUSCLE MODULATION | 2022-06-09 |
20220175714 | USE OF RIVASTIGMINE IN PREPARATION OF ANTI-RADIATION MEDICAMENT | 2022-06-09 |
20220175715 | CARBOPLATIN COMPLEX AND PHARMACEUTICAL PREPARATION THEREOF | 2022-06-09 |
20220175716 | TREATMENT OF CIRCADIAN RHYTHM DISORDERS | 2022-06-09 |
20220175717 | PHENPROCOUMON TTS | 2022-06-09 |
20220175718 | TRANSDERMAL PHARMACEUTICAL FORMULATIONS FOR THE TREATMENT OF CANCER | 2022-06-09 |
20220175719 | DISSOLVABLE THC BEVERAGE TABLET PRODUCTION METHOD | 2022-06-09 |
20220175720 | COMBINED PREPARATION COMPRISING AN ANTHOCYANIN COMPOSITION AND AN ANTIVIRAL AGENT | 2022-06-09 |
20220175721 | TREATMENT FOR POLYCYSTIC OVARIAN SYNDROME (PCOS) | 2022-06-09 |
20220175722 | DEGRADERS OF FIBROBLAST GROWTH FACTOR RECEPTOR 2 (FGFR2) | 2022-06-09 |
20220175723 | METHODS AND COMPOSITIONS RELATING TO INHIBITION OF ALDEHYDE DEHYDROGENASES FOR TREATMENT OF CANCER | 2022-06-09 |
20220175724 | Prophylactic or Therapeutic Agent for Cancer | 2022-06-09 |
20220175725 | COMBINATION OF IMMUNOTHERAPIES WITH MDM2 INHIBITORS | 2022-06-09 |
20220175726 | STABLE PRESERVATIVE-FREE MYDRIATIC AND ANTI-INFLAMMATORY SOLUTIONS FOR INJECTION | 2022-06-09 |
20220175727 | Anti-Inflammatory and Mydriatic Intracameral Solutions for Inhibition of Postoperative Ocular Inflammatory Conditions | 2022-06-09 |
20220175728 | PHARMACEUTICAL USE OF CHLOROPHYLLIDE FOR ANTI-VIRAL INFECTION | 2022-06-09 |
20220175729 | PHARMACEUTICAL USE OF CHLOROPHYLLIDE FOR CANCER THERAPY | 2022-06-09 |
20220175730 | Effects of Age-Dependent Changes in Cell Size on Endothelial Cell Growth | 2022-06-09 |
20220175731 | JAK1 PATHWAY INHIBITORS FOR THE TREATMENT OF VITILIGO | 2022-06-09 |
20220175732 | TREATMENT OF ROSACEA WITH TOPICAL COMBINATION COMPOSITIONS | 2022-06-09 |
20220175733 | METHODS AND COMPOSITIONS FOR ORAL PILOCARPINE LIQUID | 2022-06-09 |
20220175734 | USING PARASYMPATHOMIMETIC DRUGS ALONE OR, IN COMBINATION WITH ONE OR MORE ALPHA AGONISTS IN PSEUDOPHAKIC PATIENTS, TO CREATE MULTI-FOCALITY | 2022-06-09 |
20220175735 | METHODS OF TREATING PULMONARY DISEASES AND DISORDERS | 2022-06-09 |
20220175736 | SMALL MOLECULE INHIBITORS OF BACTERIAL EFFLUX PUMPS AND METHODS OF USING SAME | 2022-06-09 |
20220175737 | COMBINATION OF NITAZOXANIDE AND ELAFIBRANOR FOR THE TREATMENT OF IMMUNE DISEASES OR INFLAMMATION | 2022-06-09 |
20220175738 | Tip60 Inhibitors and Methods of Use for Cardiovascular Disease | 2022-06-09 |
20220175739 | METHOD FOR TREATING NONSENSE MUTATION MEDIATED DUCHENNE MUSCULAR DYSTROPHY IN PEDIATRIC PATIENTS | 2022-06-09 |
20220175740 | PHARMACEUTICAL COMPOSITIONS OF A SELECTIVE C-KIT KINASE INHIBITOR AND METHODS FOR MAKING AND USING SAME | 2022-06-09 |
20220175741 | COMPOSITIONS, DEVICES AND METHODS FOR TREATING AUTISM | 2022-06-09 |
20220175742 | COLLAGEN P4H1 INHIBITOR AND ITS USE | 2022-06-09 |
20220175743 | TOPICAL ROFLUMILAST FORMULATION HAVING ANTIFUNGAL PROPERTIES | 2022-06-09 |
20220175744 | COMBINATIONS OF TRANSCRIPTION INHIBITORS AND IMMUNE CHECKPOINT INHIBITORS FOR TREATMENT OF DISEASE | 2022-06-09 |
20220175745 | COMPOSITION FOR ORAL ADMINISTRATION WITH CONTROLLED RELEASE PROPERTIES COMPRISING COMPLEX OF CLAY MINERALS, METHOD FOR PREPARING SAME, AND METHOD FOR CONTROLLING RELEASE PROPERTIES | 2022-06-09 |
20220175746 | INDANE-AMINES AS PD-L1 ANTAGONISTS | 2022-06-09 |
20220175748 | ANTICOAGULANT COMPOSITIONS AND USES THEREOF | 2022-06-09 |
20220175749 | LANABECESTAT FOR WEIGHT LOSS | 2022-06-09 |
20220175750 | SUSTAINED RELEASE FORMULATION FOR LOCAL DELIVERY OF CDK9 INHIBITORS | 2022-06-09 |
20220175751 | Methods of Treating Ovarian Cancer | 2022-06-09 |
20220175752 | Methods of Treating Ovarian Cancer | 2022-06-09 |
20220175753 | TREATING OF SIDE-EFFECTS RESULTING FROM CHEMODENERVATION | 2022-06-09 |
20220175754 | P97 INHIBITORS FOR TREATING CANCER AND NEURODEGENERATIVE DISORDERS | 2022-06-09 |
20220175755 | METHODS OF TREATING TOBACCO SMOKING ADDICTION, AND TREATING NICOTINE AND TOBACCO SMOKING ADDICTION | 2022-06-09 |
20220175756 | APPLICATION OF COMBINATION OF QUINOLINE DERIVATIVE AND IMMUNOMODULATOR IN PREPARATION OF ANTITUMOR DRUGS | 2022-06-09 |
20220175757 | Processes for Preparing Quinoline Compounds and Pharmaceutical Compositions Containing Such Compounds | 2022-06-09 |
20220175758 | COMPOSITIONS AND METHODS TO TREAT NON-ALCOHOLIC FATTY LIVER DISEASES (NAFLD) | 2022-06-09 |
20220175759 | COMBINED PHARMACEUTICAL COMPOSITION FOR TREATING SMALL CELL LUNG CANCER | 2022-06-09 |
20220175760 | PHARMACEUTICAL FORMULATIONS | 2022-06-09 |